Fig. 1From: Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host diseaseKaplan–Meier curves for overall survival in patients with RR-aGvHD. Curves indicate overall survival (OS) for children (blue) and adults (red) with ruxolitinib-refractory acute graft-versus-host disease treated with MSC-FFMBack to article page